# Implementing LISA Surfactant in Nigeria

> **NCT05714865** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 349 (actual)

## Conditions studied

- Respiratory Distress Syndrome
- Neonatal Death

## Interventions

- **DRUG:** Surfactant

## Key facts

- **NCT ID:** NCT05714865
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-25
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 349 (ACTUAL)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05714865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05714865, "Implementing LISA Surfactant in Nigeria". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05714865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*